Innovative inhaler: the Novolizer
On the global market
The Novolizer is now on sale on the global market and the number of asthma and COPD drugs for which it can be used will soon be increased. Various pharmaceutical companies are involved in its further development. In addition, De Boer and Frijlink and their team of specialists are currently working on a special disposable inhaler (the Twincer) for administering drugs for conditions such as cystic fibrosis and tuberculosis. The pharmaceutical industry is already keenly anticipating this new inhaler, as it is also suitable for administering flu jabs and vaccinations against various other infectious diseases. It is thought that the Twincer will be available for use by patients in just a few years.
On 21 April 2010, Anne de Boer and Erik Frijlink were awarded the Wubbo Ockels prize for the successful development of this innovative Novolizer inhaler.
Last modified: | 22 May 2018 10.35 a.m. |
More news
-
15 April 2024
Single-molecule engineering niche in Gravitation research
With her expertise in single-molecule techniques, Dr. Kasia Tych (GBB) will contribute to a big Grvitation-research programme
-
15 April 2024
Night vision with artificial atoms
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
09 April 2024
University of Groningen to become member of the 4TU Stan Ackermans Institute
Through this membership, the two EngD programmes in Autonomous Systems and in Sustainable Process Design at the Faculty of Science and Engineering will be added to this partnership with the 4TU from September 2024